These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12653833)

  • 21. Accelerated nephrotoxic nephritis is exacerbated in C1q-deficient mice.
    Robson MG; Cook HT; Botto M; Taylor PR; Busso N; Salvi R; Pusey CD; Walport MJ; Davies KA
    J Immunol; 2001 Jun; 166(11):6820-8. PubMed ID: 11359841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different mediator systems in biphasic heterologous phase of anti-GBM nephritis in mice.
    Feith GW; Assmann KJ; Bogman MJ; van Gompel AP; Schalkwijk J; Koene RA
    Nephrol Dial Transplant; 1996 Apr; 11(4):599-607. PubMed ID: 8671846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple autoantibodies form the glomerular immune deposits in patients with systemic lupus erythematosus.
    Mannik M; Merrill CE; Stamps LD; Wener MH
    J Rheumatol; 2003 Jul; 30(7):1495-504. PubMed ID: 12858447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential.
    Zhao Z; Weinstein E; Tuzova M; Davidson A; Mundel P; Marambio P; Putterman C
    Arthritis Rheum; 2005 Feb; 52(2):522-30. PubMed ID: 15693007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IgG and IgA autoantibodies to C1q in systemic and renal diseases.
    Siegert CE; Daha MR; Halma C; van der Voort EA; Breedveld FC
    Clin Exp Rheumatol; 1992; 10(1):19-23. PubMed ID: 1348021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoantibodies to the collagen-like region of C1q are strongly associated with classical pathway-mediated hypocomplementemia in systemic lupus erythematosus.
    Frémeaux-Bacchi V; Weiss L; Demouchy C; Blouin J; Kazatchkine MD
    Lupus; 1996 Jun; 5(3):216-20. PubMed ID: 8803893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful treatment of experimental glomerulonephritis with IdeS and EndoS, IgG-degrading streptococcal enzymes.
    Yang R; Otten MA; Hellmark T; Collin M; Björck L; Zhao MH; Daha MR; Segelmark M
    Nephrol Dial Transplant; 2010 Aug; 25(8):2479-86. PubMed ID: 20219834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Occurrence of anti-C1q antibodies in IgA nephropathy.
    Gunnarsson I; Rönnelid J; Lundberg I; Jacobson SH
    Nephrol Dial Transplant; 1997 Nov; 12(11):2263-8. PubMed ID: 9394309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between the presence of anti-C1q antibodies and active nephritis in patients with systemic lupus erythematosus.
    Gargiulo Mde L; Gómez G; Khoury M; Collado MV; Suárez L; Álvarez C; Sarano J
    Medicina (B Aires); 2015; 75(1):23-8. PubMed ID: 25637896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoantibodies against mannose-binding lectin in systemic lupus erythematosus.
    Seelen MA; Trouw LA; van der Hoorn JW; Fallaux-van den Houten FC; Huizinga TW; Daha MR; Roos A
    Clin Exp Immunol; 2003 Nov; 134(2):335-43. PubMed ID: 14616796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis.
    Trendelenburg M; Lopez-Trascasa M; Potlukova E; Moll S; Regenass S; Frémeaux-Bacchi V; Martinez-Ara J; Jancova E; Picazo ML; Honsova E; Tesar V; Sadallah S; Schifferli J
    Nephrol Dial Transplant; 2006 Nov; 21(11):3115-21. PubMed ID: 16877491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation between the renal C1q deposition and serum anti-C1q antibody: a potential role of anti-C1q antibody in lupus nephritis.
    Chen PC; Wang CR; Liu MF; Chen FF; Liang CC
    Asian Pac J Allergy Immunol; 2002 Dec; 20(4):223-7. PubMed ID: 12744622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients.
    Katsumata Y; Miyake K; Kawaguchi Y; Okamoto Y; Kawamoto M; Gono T; Baba S; Hara M; Yamanaka H
    Arthritis Rheum; 2011 Aug; 63(8):2436-44. PubMed ID: 21506094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased IgG on cell-derived plasma microparticles in systemic lupus erythematosus is associated with autoantibodies and complement activation.
    Nielsen CT; Østergaard O; Stener L; Iversen LV; Truedsson L; Gullstrand B; Jacobsen S; Heegaard NH
    Arthritis Rheum; 2012 Apr; 64(4):1227-36. PubMed ID: 22238051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-C1q antibodies and systemic lupus erythematosus in the Tunisian population.
    Trad B; Ben Hassine H; Khalifa M; Idriss N; Slama F; Bahri F; Laouani Kechrid C; Boukadida J; Sghiri R
    Pathol Biol (Paris); 2013 Jun; 61(3):113-6. PubMed ID: 23399411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoantibodies against complement C1q specifically target C1q bound on early apoptotic cells.
    Bigler C; Schaller M; Perahud I; Osthoff M; Trendelenburg M
    J Immunol; 2009 Sep; 183(5):3512-21. PubMed ID: 19648280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IgG autoantibodies to complement C1q in pediatric-onset systemic lupus erythematosus.
    Ravelli A; Wisnieski JJ; Ramenghi B; Ballardini G; Zonta L; Martini A
    Clin Exp Rheumatol; 1997; 15(2):215-9. PubMed ID: 9196878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IgG subclasses of antibodies to the collagen-like region of C1q in patients with systemic lupus erythematosus.
    Uwatoko S; Mannik M
    Arthritis Rheum; 1989 Dec; 32(12):1601-3. PubMed ID: 2512937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IgG autoantibodies against C1q are correlated with nephritis, hypocomplementemia, and dsDNA antibodies in systemic lupus erythematosus.
    Siegert C; Daha M; Westedt ML; van der Voort E; Breedveld F
    J Rheumatol; 1991 Feb; 18(2):230-4. PubMed ID: 2023216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.